← All lessons
Lesson 16 of 31 · Lab panels
A routine liver blood test beat a common score as a first check
A simple liver marker from a standard blood draw just earned a bigger role in how liver health gets checked.
Hosted video lesson
Coming soon
Our Academy host will teach this lesson on camera. Read it below today.
What the research found
- 1In a Lancet study of more than 1,500 people with fatty liver disease, the routine gamma-GT (GGT) blood test did better than the widely used FIB-4 score as a first-line assessment tool.
- 2The researchers proposed a two-step path: start with GGT, then confirm how serious the disease is with a liver stiffness scan (FibroScan) or an ELF blood test.
- 3Fatty liver disease affects up to 1 in 3 adults worldwide and as many as 7 in 10 people with obesity or type 2 diabetes.
The fine print. Participants were adults with fatty liver disease already seen in specialist liver centers, so the GGT-first path still needs testing in everyday primary care before guidelines adopt it. No single blood test diagnoses liver disease, and spotting active liver inflammation is still hard: only one specialized protein panel met the study's accuracy bar for it.
Ask a licensed provider
"Is GGT on my blood panel, and if my liver numbers look off, should we follow up with a liver stiffness scan or an ELF test?"
Source: Vali Y, Wonders K, Lee J, et al.; LITMUS Investigators (Anstee QM, senior author). Lancet. 2026;408(10566):1850-1865 (doi:10.1016/S0140-6736(26)01145-1; PMID 42956772). Open the paper
For your business
Post it as a two-step carousel, a routine blood marker first and a follow-up scan second, and invite viewers to review their liver numbers with a licensed provider.
Post-ready caption
A routine liver blood test beat a common score as a first check
What should be on a modern lab panel?
In a Lancet study of more than 1,500 people with fatty liver disease, the routine gamma-GT (GGT) blood test did better than the widely used FIB-4 score as a first-line assessment tool. The researchers proposed a two-step path: start with GGT, then confirm how serious the disease is with a liver stiffness scan (FibroScan) or an ELF blood test.
The fine print: Participants were adults with fatty liver disease already seen in specialist liver centers, so the GGT-first path still needs testing in everyday primary care before guidelines adopt it. Evidence level: Moderate.
Ask a licensed provider: "Is GGT on my blood panel, and if my liver numbers look off, should we follow up with a liver stiffness scan or an ELF test?" Start at hoolongevity.com.
Want your own branded telehealth storefront? HOO Health builds it for you: $0 to start, no sign-up fee, no MLM, no quotas. joinhoohealth.com
Source: Vali Y, Wonders K, Lee J, et al.; LITMUS Investigators (Anstee QM, senior author). Lancet. 2026;408(10566):1850-1865 (doi:10.1016/S0140-6736(26)01145-1; PMID 42956772).
Education only, not medical advice. Rx programs require an online visit with a licensed provider. Results vary.
#HealthEducation #Labpanels #Longevity #Wellness #Telehealth #HOOHealth
HOO LONGEVITY